Peking University People's Hospital;
Beijing 100044;
China;
The Institute of Hematology & Blood Diseases Hospital;
Chinese Academy of Medical Science & Peking Union Medical College;
Tianjin 300020;
China;
Fujian Medical University Union Hospital;
Fuzhou 350004;
China;
The First Affiliated Hospital with Nanjing Medical University;
Nanjing 210029;
China;
The First Affiliated Hospital of The College of Medicine;
Zhejiang University;
Hangzhou 310058;
China;
Guangzhou Nanfang Hospital;
Guangzhou 510515;
China;
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine;
Shanghai 200025;
China;
West China Hospital;
Sichuan University;
Chengdu 610041;
China;
The First Affiliated Hospital of Soochow University;
Suzhou 215006;
China;
Changhai Hospital of Shanghai;
Shanghai 200433;
China;
chronic; myeloid; leukemia; (CML); dasatinib; tyrosine; kinase; inhibitor; long-term; follow-up;